clinical trial · NCT02718001
Edwards EVOQUE Eos MISCEND Study
Edwards Lifesciences·N/A·active not recruiting·n = 123
Mitral Valve Regurgitation (Degenerative or Functional)Edwards EVOQUE Eos Mitral Valve Replacement System
brief summary
Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system
started
Feb 6, 2015
primary completion
Apr 30, 2028
completion
Apr 30, 2033
last updated
Apr 13, 2026
detailed description
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system.
official title
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol